Artikel
Lesedauer von 6 Min.
09. September 2026
GEMEINSCHAFTSGESUNDHEIT UND GLOBALE GESUNDHEIT
{{cartTotalQuantity}}
Molekulardiagnostik-Menü
Instrumente und Software
Die Lösungen von Cepheid
Tests an jedem Ort
Antibiotic Stewardship
Cepheid’s Insights
Webinare
Cepheid RADAR
Support Center
Kontaktaufnahme
Über Cepheid
Mission und Geschichte
Veranstaltungen
Vertriebspartner
Zusammenarbeit mit Cepheid
Innovation bei Cepheid
Das Cepheid Motorrad
Neuigkeiten
Unser Leitungsteam
Karriere
WHO EUL
Xpert® Hemorrhagic Fever Panel
When Clarity Matters Most.
Rapid Answers. Confident Action. No Compromise.
WHO EUL only. Eventuell nicht in allen Ländern erhältlich.
Der Bedarf
Die Lösung
Der Vorteil
Rapidly identify patients with suspected viral hemorrhagic fever
Support timely infection control and outbreak response
1. CDC. Screening and Evaluating an Ill Person for Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/diagnosis-testing/index.html
2. CDC. Infection Prevention and Control for Patients with Suspected or Confirmed Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/index.html [ecdc.europa.eu]
3. WHO. Lassa Fever Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/lassa-fever [ijprems.com]
4. CDC. Lassa Fever Fact Sheet. https://stacks.cdc.gov/view/cdc/12236/cdc_12236_DS1.pdf [cdc.gov]
5. Weltgesundheitsorganisation. Marburg virus disease - Equatorial Guinea and the United Republic of Tanzania. Disease Outbreak News, 08. Mai 2023. [who.int]
6. Centers for Disease Control and Prevention (CDC). History of Marburg Outbreaks. Updated 2025. [cdc.gov]
7. Weltgesundheitsorganisation. Crimean-Congo hemorrhagic fever: Fact Sheet. Updated 20. Februar 2025. [who.int]
8. UK Health Security Agency. Crimean-Congo hemorrhagic fever: origins, reservoirs, transmission and guidelines. Updated 2025. [gov.uk]
Xpert Hemorrhagic Fever Panel:
9. FDA 510(k) Decision Summary, Xpert® Hemorrhagic Fever Panel (K253653). Inactivation study results demonstrating viral inactivation during sample preparation are described in the submission documentation (see p. 23). Verfügbar unter: https://www.accessdata.fda.gov/cdrh_docs/reviews/K253653.pdf.
1. CDC. Screening and Evaluating an Ill Person for Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/diagnosis-testing/index.html
2. CDC. Infection Prevention and Control for Patients with Suspected or Confirmed Viral Hemorrhagic Fevers. https://www.cdc.gov/viral-hemorrhagic-fevers/hcp/infection-control/index.html [ecdc.europa.eu]
Datenblatt
ENG
SDB
ENG
SDB
FRANZÖSISCH
Packungsbeilage
ENG
Cartridge Preparation
ENG
Artikel
Lesedauer von 6 Min.
09. September 2026
GEMEINSCHAFTSGESUNDHEIT UND GLOBALE GESUNDHEIT
Artikel
Lesedauer von 5 Min.
12. Juni 2026
GEMEINSCHAFTSGESUNDHEIT UND GLOBALE GESUNDHEIT